Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420160 · ClinicalTrials.gov registry record · Phase 2
Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?
A Phase 2 study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 59
- Enrollment target
NCT00420160: Completed Phase 2 study, sponsored by The Miriam Hospital.
NCT00420160 is a Phase 2 study that has completed, run by The Miriam Hospital. The registered enrollment target is 59 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00420160, a Phase 2 study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy women. We hypothesize that participants in the smoking cessation plus moderate intensity exercise condition will be more likely to quit smoking than participants in the smoking cessation treament plus contact control condition.
Interventions
- BEHAVIORAL Smoking cessation treatment plus moderate intensity exercise
- BEHAVIORAL Smoking cessation treatment plus health education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
What the finished NCT00420160 record still lists
NCT00420160 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Smoking cessation treatment plus moderate intensity exercise is the first listed.
NCT00420160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00420160 about?
NCT00420160 is a clinical study titled "Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?". This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy wome...
What is the current status of trial NCT00420160?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2007-02. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00420160?
The interventions under investigation include: Smoking cessation treatment plus moderate intensity exercise (BEHAVIORAL), Smoking cessation treatment plus health education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00420160?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00420160's enrollment target sits among peer trials
59 1133rd of 2000 higher than 866 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia